J9041 HCPCS code: Injection, bortezomib, 0.1 mg
J9041 is the HCPCS Level II code for injection, bortezomib, 0.1 mg. In 2024 Medicare paid an average of $1.40 per service for J9041 across 3,071,661 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 35 per day on DME suppliers. Medicare volume fell 13% from 2022 to 2024 (3,523,341 to 3,071,661 services). In 2024, about 3,936 clinicians billed Medicare for J9041 for 6,114 beneficiaries; Florida, Texas, California accounted for 31% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2005-01-01 |
| Last action effective | 2023-01-01 |
Who bills J9041 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 3,936 |
| Medicare beneficiaries | 6,114 |
| States with claims | 44 |
| Share of services in top 3 states (Florida, Texas, California) | 31% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9041, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 3,523,341 | 7,015 | $38.84 | $30.96 |
| 2023 | 3,407,731 | 6,688 | $5.04 | $3.97 |
| 2024 | 3,071,661 | 6,114 | $1.79 | $1.40 |
States with the most J9041 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 363,756 | $1.42 |
| Texas | 299,838 | $1.40 |
| California | 292,238 | $1.40 |
| Virginia | 182,125 | $1.41 |
| Illinois | 166,659 | $1.41 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 35 | Prescribing Information |
| outpatient hospital claims | 35 | Clinical: Data |
| practitioner claims | 35 | Clinical: Data |
What changed for J9041
- 2005-01-01: J9041 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9041?
J9041 is the HCPCS Level II code for injection, bortezomib, 0.1 mg. Short descriptor: "Injection, bortezomib, 0.1mg".
How much does Medicare pay for J9041?
In 2024, the average Medicare payment was $1.40 per service (average allowed $1.79).
Does Medicare cover J9041?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9041 can be billed per day?
35 on DME suppliers; 35 on outpatient hospital claims; 35 on practitioner claims (NCCI medically unlikely edits).
Related J90 codes
- J9000 — Injection, doxorubicin hydrochloride, 10 mg
- J9010 — Injection, alemtuzumab, 10 mg
- J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 — Injection, aldesleukin, per single use vial
- J9017 — Injection, arsenic trioxide, 1 mg
- J9019 — Injection, asparaginase (erwinaze), 1,000 iu
- J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 — Injection, atezolizumab, 10 mg
- J9023 — Injection, avelumab, 10 mg
- J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025 — Injection, azacitidine, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9041
- Watch J9041 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9041
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.